GOLGA2P10: A Potential Drug Target and Biomarker (G80154)

Target Name: GOLGA2P10

NCBI ID: G80154

GOLGA2P10

Other Name(s): GOLGA2 pseudogene 10

GOLGA2P10: A Potential Drug Target and Biomarker

GOLGA2P10 is a pseudogene located on chromosome 16 that encodes for the protein GOLGA2. GOLGA2 is a transmembrane protein that is involved in various cellular processes, including intracellular signaling, cell adhesion, and neurotransmission. The GOLGA2 gene has been implicated in the development and progression of various diseases, including neurological and psychiatric disorders.

Recent studies have identified GOLGA2 as a potential drug target and biomarker for various diseases, including Alzheimer's disease, Parkinson's disease, and schizophrenia. GOLGA2 has been shown to be overexpressed or underexpressed in the brains of individuals with these disorders, which suggests that targeting GOLGA2 may be a promising strategy for the development of new treatments for these diseases.

One of the key challenges in studying GOLGA2 is its complex structure and the limited information that is available about its function. However, recent studies have provided some insight into the biology of GOLGA2 and its potential role in disease.

GOLGA2 is a transmembrane protein that is involved in the regulation of various cellular processes, including intracellular signaling and cell adhesion. It is composed of a transmembrane domain, a cytoplasmic domain, and an extracellular domain. The transmembrane domain is responsible for the protein's transmembrane properties and is involved in the regulation of ion channels and the transfer of signals across the membrane. The cytoplasmic domain is involved in the protein's stability and functions as a protein within the cytoplasm. The extracellular domain is involved in the protein's interactions with other cellular components and may be involved in its intracellular signaling functions.

GOLGA2 has been shown to be involved in various signaling pathways, including the TGF-β pathway and the Wnt pathway. The TGF-β pathway is a well-established pathway that is involved in the regulation of cellular processes, including cell growth, differentiation, and inflammation. The Wnt pathway is a signaling pathway that is involved in the regulation of cell growth, differentiation, and development. GOLGA2 has been shown to be involved in the regulation of these pathways and has been implicated in the development and progression of various diseases.

In addition to its involvement in signaling pathways, GOLGA2 has also been shown to be involved in the regulation of cellular processes that are important for maintaining cellular structure and homeostasis. GOLGA2 has also been shown to be involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. It has also been shown to be involved in the regulation of cell migration, which is the process by which cells move from their place of origin to their final destination in the body.

GOLGA2 has also been shown to be involved in the regulation of neurotransmission, which is the process by which neurons transmit signals between neurons. It has been shown to be involved in the regulation of neurotransmitter release and uptake, as well as the regulation of neurotransmitter receptors. These functions are important for the proper functioning of the nervous system and are implicated in the development and progression of various psychiatric and neurological disorders.

In conclusion, GOLGA2P10 is a pseudogene that has been shown to be involved in various cellular processes that are important for the development and progression of various diseases. The potential drug target and biomarker status of GOLGA2P10 makes it an attractive target for researchers to investigate and develop new treatments for these diseases. Further studies are needed to fully understand the functions of GOLGA2P10 and its potential as a drug

Protein Name: GOLGA2 Pseudogene 10

The "GOLGA2P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA2P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets